As innovations in science and technology disrupt the status quo, developments such as pharmacogenetic testing in group benefits plans and robo-advisors in the pension industry are offering new options for plan members, a panel of experts said at an event on Wednesday. The acceptance of pharmacogenetic testing is growing as 88 per cent of doctors believe it will be the […]